Xiang, Ling
Xiao, Yi
Xu, Zhiquan
Luo, Haoyun
Ren, Xiaorui
Wei, Qi
Zhu, Zhiyong
Jiang, Yahui
Tang, Yunhao
He, Hongmei
Zhou, Zhihang
Gu, Haitao
Wang, Yaxu
Peng, Linglong http://orcid.org/0000-0001-5774-3110
Funding for this research was provided by:
Chongqing Science and Technology Foundation (CSTB2022NSCQ-MSX1005, cstc2021jcyj-msxmX0153, cstc2021jcyj-msxmX0112)
Kuanren Talents Project of the Second Affiliated Hospital of Chongqing Medical University (kryc-yq-2110)
Article History
Received: 18 July 2023
Accepted: 22 September 2023
First Online: 2 October 2023
Declarations
:
: The study is in line with the Helsinki Declaration. The PLCO Cancer Screening Trial design was approved by the Institutional Review Board of the National Cancer Institute and each of the screening centers. Participants provided written informed consent prior to participation in this study.
: Not applicable.
: The authors declare no competing interests.